Session Information
Date: Monday, November 13, 2023
Title: (1442–1487) SLE – Diagnosis, Manifestations, & Outcomes Poster II
Session Type: Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose: Lupus nephritis (LN) is one of major organ involvement of SLE and renal biopsy is commonly performed in SLE patients suspected of having LN to assess the severity of renal damage and guide treatment decisions. However, there have been cases where renal biopsies performed in SLE patients resulted in the diagnosis of other renal diseases, such as IgA nephropathy. The prevalence and similarities between IgA nephropathy and LN in SLE patients have not been extensively studied. This study aims to investigate the characteristics of SLE patients diagnosed with renal disease other than LN, with a focus on IgA nephropathy and its similarities and differences with class II LN.
Methods: A retrospective analysis was conducted on SLE patients who underwent renal biopsies between April 1997 and October 2022 at a single tertiary care academic center. Patients diagnosed with renal diseases other than LN were identified, with a particular focus on IgA nephropathy. Baseline characteristics, laboratory findings, and renal biopsy pathologic findings were collected and statistical analyses were performed.
Results: Among 483 SLE patients who underwent renal biopsies, 25 (5%) were diagnosed with renal diseases other than LN. The most common non-LN pathology was IgA nephropathy, accounting for 28% of cases. A comparison between patients with IgA nephropathy and class II LN showed no significant differences in age, sex, SLEDAI, eGFR or UPCR. In pathologic finding, IgA nephropathy exhibited predominant IgA staining with higher intensity, while class II LN demonstrated “Full house” pattern. Long-term renal outcomes did not significantly differ between the two groups.
Conclusion: SLE patients can have renal diseases other than LN and IgA nephropathy was the most observed non-LN pathology in SLE patients. Comparison between IgA nephropathy and class II LN revealed similarities in clinical and pathological characteristics, although there were differences in immunofluorescence findings. The long-term renal outcomes between the two groups have no significant differences. These results contribute to a better understanding of the diagnostic accuracy of renal diseases other than LN in SLE patients.
To cite this abstract in AMA style:
Kang E, Hong S. A Comparative Study of Lupus Nephritis Class II and IgA Nephropathy: Renal Disease Other Than Lupus Nephritis in Systemic Lupus Erythematosus Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/a-comparative-study-of-lupus-nephritis-class-ii-and-iga-nephropathy-renal-disease-other-than-lupus-nephritis-in-systemic-lupus-erythematosus-patients/. Accessed .« Back to ACR Convergence 2023
ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-comparative-study-of-lupus-nephritis-class-ii-and-iga-nephropathy-renal-disease-other-than-lupus-nephritis-in-systemic-lupus-erythematosus-patients/